logo

G1 Therapeutics, Inc. (GTHX)



Trade GTHX now with
  Date
  Headline
11/8/2018 1:23:35 PM Wedbush Is Raising G1 Therapeutics, Inc. (GTHX) 3Q19 Estimate To -0.55 From -0.68
11/8/2018 1:23:22 PM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) 2Q19 Estimate To -0.54 From -0.68
11/8/2018 1:23:08 PM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) 1Q19 Estimate To -0.54 From -0.68
11/8/2018 1:22:56 PM Wedbush Is Raising G1 Therapeutics, Inc. (GTHX) 2018 Estimate To -2.48 From -2.75
11/8/2018 1:22:43 PM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) 4Q18 Estimate To -0.56 From -0.69
10/21/2018 9:41:52 AM G1 Presents Addl Data From Phase 2 Trial Of Trilaciclib In Combination With Etoposide/Carboplatin For Treatment Of SCLC
10/9/2018 7:11:02 AM G1 Therapeutics To Present Addl Data From Randomized Phase 2 Trial Of Trilaciclib With Etoposide/Carboplatin At ESMO
9/19/2018 10:24:11 AM Wedbush Is Raising G1 Therapeutics, Inc. (GTHX) FY19 Estimate To -2.72 From -3.07
9/19/2018 10:23:56 AM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) Q4 19 Estimate To -0.68 From -0.77
9/19/2018 10:23:48 AM Wedbush Is Raising G1 Therapeutics, Inc. (GTHX) Q3 19 Estimate To -0.68 From -0.77
9/19/2018 10:23:37 AM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) Q2 19 Estimate To -0.68 From -0.76
9/19/2018 10:23:27 AM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) Q1 19 Estimate To -0.68 From -0.77
9/19/2018 10:23:12 AM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) FY18 Estimate To -2.75 From -2.83
9/19/2018 10:22:27 AM Wedbush Is Increasing G1 Therapeutics, Inc. (GTHX) Q4 18 Estimate To -0.69 From -0.76
9/19/2018 10:22:13 AM Wedbush Is Raising G1 Therapeutics, Inc. (GTHX) Q3 18 Estimate To -0.72 From -0.73
9/18/2018 9:41:23 PM G1 Therapeutics Prices Underwritten Public Offering Of 3 Mln Shares At $60.00/shr
9/17/2018 4:04:31 PM G1 Therapeutics Announces Proposed Offering Of Common Stock
9/13/2018 7:07:28 AM G1 Therapeutics Names Garry Nicholson To Its Board
7/9/2018 7:04:19 AM G1 Therapeutics Names John Demaree As Chief Commercial Officer And Stillman Hanson As General Counsel
6/8/2018 7:01:10 AM G1 Therapeutics Appoints Cynthia Schwalm And Willie Deese To Board